WVE · Wave Life Sciences, Inc. · Share Buybacks
$3.13
-0.03 (-0.79%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$617.33M
Shares
197.23M
Volume · Nov 13
2.66M
Avg daily vol (3M)
3.16M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2019-05-10 | 2024-11-12 | $250,000,000 | — | — | 10-Q , filed 2026-07-30 |
Key facts
CIK
1631574
CUSIP
94352A104
13F (30d)
161 filings
146 filers
Visit website
Investor relations